Skip to main content

Table 3 Causes of death

From: Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Cause of death

ATG-PTCy cohort (n = 16)

ATG cohort (n = 27)

Relapse

9 (56%)

8 (30%)

GVHD

0

7(26%)

Infection other than CMV/EBV

5 (31%)

10 (37%)

CMV disease

1 (6%)

0

Organ failure

1 (6%)

2 (7%)

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us